ATE289597T1 - Mercapto derivate mit metallopeptidase(ace/nep) inhibiernder wirkung - Google Patents

Mercapto derivate mit metallopeptidase(ace/nep) inhibiernder wirkung

Info

Publication number
ATE289597T1
ATE289597T1 AT96943903T AT96943903T ATE289597T1 AT E289597 T1 ATE289597 T1 AT E289597T1 AT 96943903 T AT96943903 T AT 96943903T AT 96943903 T AT96943903 T AT 96943903T AT E289597 T1 ATE289597 T1 AT E289597T1
Authority
AT
Austria
Prior art keywords
pct
nep
ace
metallopeptidase
inhibiting effect
Prior art date
Application number
AT96943903T
Other languages
English (en)
Inventor
Franco Pellacini
Stefano Romagnano
Gabriele Norcini
Francesco Santangelo
Claudio Semeraro
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Application granted granted Critical
Publication of ATE289597T1 publication Critical patent/ATE289597T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Seasonings (AREA)
AT96943903T 1995-12-28 1996-12-09 Mercapto derivate mit metallopeptidase(ace/nep) inhibiernder wirkung ATE289597T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI002772A IT1277736B1 (it) 1995-12-28 1995-12-28 Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
PCT/EP1996/005496 WO1997024341A1 (en) 1995-12-28 1996-12-09 Thiol derivatives with metallopeptidase (ace/nep) inhibitory activity

Publications (1)

Publication Number Publication Date
ATE289597T1 true ATE289597T1 (de) 2005-03-15

Family

ID=11372826

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96943903T ATE289597T1 (de) 1995-12-28 1996-12-09 Mercapto derivate mit metallopeptidase(ace/nep) inhibiernder wirkung

Country Status (15)

Country Link
US (1) US6166051A (de)
EP (1) EP0883612B1 (de)
KR (1) KR19990076808A (de)
CN (1) CN1108295C (de)
AT (1) ATE289597T1 (de)
AU (1) AU706978B2 (de)
CA (1) CA2241452A1 (de)
CZ (1) CZ295804B6 (de)
DE (1) DE69634387D1 (de)
EA (1) EA002339B1 (de)
HU (1) HUP9903840A3 (de)
IT (1) IT1277736B1 (de)
MX (1) MX9805168A (de)
WO (1) WO1997024341A1 (de)
ZA (1) ZA9610819B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805259B1 (fr) * 2000-02-17 2002-03-29 Inst Nat Sante Rech Med Nouveaux derives d'aminoacides n-mercaptoacyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US8307671B2 (en) * 2008-09-22 2012-11-13 Jungerhans Robert R J Purification of gases in synthesis gas production process

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199512A (en) * 1976-05-10 1980-04-22 E. R. Squibb & Sons, Inc. Compounds for alleviating hypertension
EP0566157A1 (de) * 1986-06-20 1993-10-20 Schering Corporation Hemmer der neutralen Metalloendopeptidase zur Behandlung von Hypertension
FR2652087B1 (fr) * 1989-09-15 1993-10-15 Bioprojet Ste Civile Derives d'amino-acides, leur procede de preparation et leurs applications therapeutiques.
US5599951A (en) * 1989-09-15 1997-02-04 Societe Civile Bioprojet Amino acid derivatives, the process for their preparation and their applications to therapy
CA2038379C (en) * 1990-03-22 2002-11-05 Norma G. Delaney Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
US5223516A (en) * 1990-03-22 1993-06-29 E. R. Squibb & Sons, Inc. 3,3,3-trifluoro-2-mercaptomethyl-N-tetrazolyl substituted propanamides and method of using same
FR2679564A1 (fr) * 1991-07-23 1993-01-29 Inst Nat Sante Rech Med Nouveaux acylmercaptoalcanoldipeptides, leur preparation et les compositions qui les contiennent.
US5225401A (en) * 1991-08-12 1993-07-06 E. R. Squibb & Sons, Inc. Treatment of congestive heart failure
FR2682952B1 (fr) * 1991-10-25 1993-12-03 Institut Nal Sante Recherc Medic Nouveaux n-(mercaptoacyl) amino-acides, leur preparation et les compositions pharmaceutiques qui les contiennent.
AU3494093A (en) * 1993-01-22 1994-08-15 Institut National De La Sante Et De La Recherche Medicale (Inserm) S-lipophilic aliphatic carbonyl {n-mercaptoacyl-(amino acid or peptide)} compounds as antihypertensive agents
JPH0841015A (ja) * 1994-07-27 1996-02-13 Fujisawa Pharmaceut Co Ltd 新規メルカプト−アミド誘導体
IT1273455B (it) * 1995-01-27 1997-07-08 Zambon Spa Derivati tiolici ad attivita' inibitrice delle metallopeptidasi

Also Published As

Publication number Publication date
CZ204798A3 (cs) 1998-11-11
CZ295804B6 (cs) 2005-11-16
KR19990076808A (ko) 1999-10-15
AU706978B2 (en) 1999-07-01
ITMI952772A1 (it) 1997-06-28
MX9805168A (es) 1998-10-31
DE69634387D1 (de) 2005-03-31
ITMI952772A0 (de) 1995-12-28
EA002339B1 (ru) 2002-04-25
CN1108295C (zh) 2003-05-14
EP0883612B1 (de) 2005-02-23
IT1277736B1 (it) 1997-11-12
CN1268945A (zh) 2000-10-04
ZA9610819B (en) 1997-06-24
EA199800546A1 (ru) 1999-02-25
CA2241452A1 (en) 1997-07-10
AU1369197A (en) 1997-07-28
EP0883612A1 (de) 1998-12-16
US6166051A (en) 2000-12-26
WO1997024341A1 (en) 1997-07-10
HUP9903840A3 (en) 2001-12-28
HUP9903840A2 (hu) 2000-03-28

Similar Documents

Publication Publication Date Title
BR9609888A (pt) Halogenobenzimidazóis
GR3033827T3 (en) New compounds and their compositions having anti-inflammatory and anti-thrombotic activities
ES2153975T3 (es) Derivados de pirimidona con actividad antifungica.
BG103947A (en) Derivatives of 9-oxymerythromycin
TR199801229T2 (xx) ''Metalopeptidaz inhibisyon aktivitesini havi tiol t�revleri
BR9609847A (pt) Derivados de N-(4-Benzila-substituída)-2-aminolactam
AU5879798A (en) Agents inhibiting progress of pterygium and postoperative recurrence of the same
DE69402004D1 (de) Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen
ATE289597T1 (de) Mercapto derivate mit metallopeptidase(ace/nep) inhibiernder wirkung
ATE204294T1 (de) Thiol derivate mit metallopeptidase inhibierender aktivitat
IT1216104B (it) Peptidi ad attivita' farmaceutica.
ATE238299T1 (de) N-sulfonylimidazole als fungizide
DE69418110D1 (de) N-Heteroaryl substituierte Propanamid-Derivate brauchbar zur Behandlung cardiovascularer Krankheiten
DE69625482D1 (de) Phosphinsäurederivate mit metallopeptidase-inhibitorischer wirkung
IT1216103B (it) Peptidi ad attivita' farmaceutica.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties